The combined power of the Trianni and GigaGen technologies will produce an unprecedented pipeline of fully-human antibodies
February 28, 2017
GigaGen Inc., a biopharmaceutical company with patented technology for discovery of antibody therapeutics from millions-diverse immune repertoires, today announced a strategic partnership with Trianni, Inc., a biotechnology company that has developed novel mouse strains genetically engineered to express human antibodies. The partnership will use GigaGen technology to discover immuno-oncology antibody therapeutics through The Trianni Mouse platform.
“The combined power of the Trianni and GigaGen technologies will produce an unprecedented…